IFN-α13 activators are chemical compounds or biological entities that promote the expression or activity of the IFN-α13 protein, a specific subtype of the broader interferon-alpha family. Interferons are a group of signaling proteins that play a pivotal role in the innate immune response, primarily against viral infections. IFN-α13 activators work by engaging various intracellular pathways, ultimately leading to the transcription and translation of the IFN-α13 gene.
A significant portion of IFN-α13 activators can be classified based on their mechanism of action. For instance, some activators mimic viral or bacterial components, tricking the cell into believing it's under attack. Examples of this include double-stranded RNA analogs like Poly I:C and synthetic DNA sequences like CpG oligodeoxynucleotides. These compounds are recognized by specific cellular receptors, known as Toll-like receptors (TLRs), which initiate a cascade of intracellular events leading to the production of interferons. Another group of activators directly engages with intracellular sensors, such as RIG-I-like receptors or the cGAS-STING pathway, further promoting the interferon response. Yet, it's crucial to understand that while these compounds can stimulate the broader interferon-alpha family's production, the specific and preferential activation of IFN-α13 might be influenced by the cellular context, the presence of other signaling molecules, and the exact nature of the activating compound. Future research will undoubtedly shed more light on the nuances of these interactions and how specific activation of IFN-α13 might be achieved with precision.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is recognized by Toll-like receptor 7, leading to the activation of interferon-inducing pathways. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Resiquimod (R-848) activates certain pathways leading to the induction of interferon. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS stimulates Toll-like receptor 4, which can lead to interferon production as part of the innate immune response. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A TLR7 agonist, gardiquimod can stimulate interferon production. | ||||||